What Is the TriBarrier System? CIRÈLL's Scientific Foundation
Key Findings
- The TriBarrier System is a biomimetic formulation strategy combining ceramide, cholesterol, and phytosphingosine at physiological ratios to rebuild the stratum corneum's lamellar lipid structure; "Tri" (three) refers to these three foundational components.
- Clinical research indicates that the topical ceramide:cholesterol:free-fatty-acid molar ratio should fall approximately between 1:1:1 and 2:2:1 to form a functional lamellar structure in the stratum corneum.
- TriBarrier components combine well with niacinamide, panthenol, madecassoside, and ectoin; when high-concentration AHA/BHA or retinol is used, TriBarrier products should be applied after these actives.
- Strong surfactants (SLS) or alkaline-pH toners should be used with caution, as they inhibit ceramide synthesis enzymes and can weaken the TriBarrier system's effectiveness.
Have a clinical question?
Consult directly with our pharmacist.
Consult via WhatsAppPharm. Mine Ekber
Why the Skin Barrier Matters So Much
The stratum corneum has a well-characterized "brick and mortar" structure, with keratinocytes arranged between successive lipid lamellae. Within this structure, ceramide forms the scaffold, cholesterol regulates fluidity between the lamellae, and phytosphingosine both stimulates endogenous ceramide biosynthesis and provides antimicrobial activity. Together, these three molecules fill the intercellular lipid spaces, restore the lamellar phase, and reduce transepidermal water loss (TEWL) — the foundational rationale for the TriBarrier approach.
The TriBarrier System's Three Components
The TriBarrier System is formally defined as a biomimetic formulation strategy that combines the skin barrier's fundamental lipid components — ceramide, cholesterol, and phytosphingosine — at physiological molar ratios, aiming to rebuild the stratum corneum's lamellar lipid structure from outside the skin. The name "Tri" (three) refers to these three foundational components. CIRÈLL has adopted this system as the foundation of its product development philosophy within its own Biomimetic TriBarrier System framework.
The Correct Ceramide Ratio
Clinical research indicates that to form a functional lamellar structure in the stratum corneum, the topical formulation's ceramide:cholesterol:free-fatty-acid molar ratio should fall approximately between 1:1:1 and 2:2:1. Rather than a fixed percentage-by-weight threshold, establishing this ratio correctly is what determines outcome. Within CIRÈLL formulations, this balance is maintained with attention to specific ceramide subtypes (particularly CER[NP] and CER[AP]) and physiological cholesterol levels.
Which Actives Combine Well, and Which to Approach with Caution
TriBarrier components show excellent compatibility with niacinamide, panthenol, madecassoside, and ectoin, and these combinations reinforce anti-inflammatory effect. When high-concentration AHA/BHA or retinol is being used, TriBarrier products should be applied after these actives. Caution is warranted with strong surfactants (SLS) or alkaline-pH toners, since these inhibit ceramide synthesis enzymes and weaken the TriBarrier system's overall effectiveness.
Which Skin Types the TriBarrier System Suits
The TriBarrier System is suitable for all skin types experiencing barrier dysfunction: atopic/eczema-prone skin, sensitive and reactive skin, dry and dehydrated skin, rosacea-prone skin, and skin undergoing active-ingredient use (retinol, AHA/BHA) requiring concurrent barrier support.
Frequently Asked Questions
What exactly is the TriBarrier System?
It is a biomimetic formulation strategy that combines the skin barrier's fundamental lipid components — ceramide, cholesterol, and phytosphingosine — at physiological molar ratios, aiming to rebuild the stratum corneum's lamellar lipid structure from outside the skin. CIRÈLL has adopted this as the foundation of its own Biomimetic TriBarrier System.
How does the TriBarrier System repair the skin barrier? What is the mechanism?
Ceramide and cholesterol fill the gaps between the stratum corneum's intercellular lipid lamellae, physically rebuilding the barrier and reducing transepidermal water loss (TEWL). Phytosphingosine, as a pro-ceramide precursor, supports endogenous ceramide synthesis within keratinocytes while also inhibiting the NF-κB pathway to reduce pro-inflammatory cytokine release.
What percentage of ceramide should CIRÈLL TriBarrier formulations contain?
Clinical research indicates that the topical ceramide:cholesterol:free-fatty-acid molar ratio should fall approximately between 1:1:1 and 2:2:1 for functional lamellar structure formation in the stratum corneum — establishing this ratio correctly, rather than hitting a fixed percentage-by-weight threshold, is what determines outcome.
References
- Elias PM. Skin barrier function. Curr Allergy Asthma Rep. 2008;8(4):299-305.
- Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta. 2006;1758(12):2080-2095.
- van Smeden J, Janssens M, Gooris GS, Bouwstra JA. The important role of stratum corneum lipids for the cutaneous barrier function. Biochim Biophys Acta. 2014;1841(3):295-313.
- Feingold KR. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res. 2007;48(12):2529-2530.
- Mao-Qiang M, Elias PM, Feingold KR. Fatty acids are required for epidermal permeability barrier function. J Clin Invest. 1993;92(2):791-798.
- Bibel DJ, Aly R, Shinefield HR. Antimicrobial activity of sphingosines. J Invest Dermatol. 1992;98(3):269-273.
- Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol. 2002;47(2):198-208.
- Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063-1072.